For Profit Organizations Federal Grants

Showing results 576-600 of 2,912 for For Profit Organizations federal grants, government grants and loans. For detailed information on a For Profit Organizations federal grant including eligibility requirements or financial assistance, click the title.

 

Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01)
This Funding Opportunity Announcement (FOA) encourages applications to improve health outcomes for women, infants and children, by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health...
www.FederalGrantsWire.com/maternal-nutrition-and-p...

Reductions in Illicit Drug Use and Functional Outcomes (R21/R33)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for Phased Innovation (R21/R33) projects to determine whether reductions in illicit drug use are associated with positive changes in health-related and other...
www.FederalGrantsWire.com/reductions-in-illicit-dr...

Prevention Research in Mid-Life Adults (R01)
This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years.
www.FederalGrantsWire.com/prevention-research-in-m...

Prevention Research in Mid-Life Adults (R21)
This Funding Opportunity Announcement (FOA) seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and wellness as individuals age, and prevent illness and disability in later years.
www.FederalGrantsWire.com/prevention-research-in-m...

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. This FOA includes, but is not limited to, the validation of...
www.FederalGrantsWire.com/assay-validation-for-hig...

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
The purpose of this Funding Opportunity Announcement (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. This FOA includes, but is not limited to, the validation of...
www.FederalGrantsWire.com/assay-validation-for-hig...

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)
This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. These awards will support...
www.FederalGrantsWire.com/exploratorydevelopmental...

Basic Cancer Research in Cancer Health Disparities (R01)
This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants (R01)...
www.FederalGrantsWire.com/basic-cancer-research-in...

Drug Abuse Prevention Intervention Research (R01)
This Funding Opportunity Announcement (FOA) encourages R01 grant applications for research that will employ rigorous scientific methods to test theoretically derived hypotheses to increase understanding of the science of drug use prevention within...
www.FederalGrantsWire.com/drug-abuse-prevention-in...

Drug Abuse Prevention Intervention Research (R03)
This Funding Opportunity Announcement (FOA) encourages R03 grant applications for research that will employ rigorous scientific methods to test theoretically derived hypotheses to increase understanding of the science of drug use prevention within...
www.FederalGrantsWire.com/drug-abuse-prevention-in...

Drug Abuse Prevention Intervention Research (R21)
This Funding Opportunity Announcement (FOA) encourages R21 grant applications for research that will employ rigorous scientific methods to test theoretically derived hypotheses to increase understanding of the science of drug use prevention within...
www.FederalGrantsWire.com/drug-abuse-prevention-in...

Cutting-Edge Basic Research Awards (CEBRA) (R21)
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports...
www.FederalGrantsWire.com/cutting-edge-basic-resea...

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research (U01)
The goal of this interagency funding opportunity announcement (FOA) is to support the development of multiscale models to accelerate biological, biomedical, behavioral, environmental and clinical research. The NIH, ARO, DOE, FDA, NASA, NSF, and ONR...
www.FederalGrantsWire.com/predictive-multiscale-mo...

NIA Academic Leadership Career Award (K07)
The objective of the NIA Research Leadership Career Award (K07) is to provide support for more senior investigators who have the expertise and leadership skills to enhance the aging and geriatric research capacity within their academic institution.
www.FederalGrantsWire.com/nia-academic-leadership-...

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22)
The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly qualified dentists in NIH Intramural postdoctoral fellowship positions with an opportunity to receive further mentored...
www.FederalGrantsWire.com/nidcr-dentist-scientist-...

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical...
www.FederalGrantsWire.com/academic-industrial-part...

NIMH Administrative Supplement Program Providing Research Experiences for Physicians and Medical Students from Diverse Backgrounds
The purpose of the NIMH Administrative Supplement Providing Research Experiences for Physicians and Medical Students from Diverse Backgrounds is to support advanced research experiences for outstanding early career physicians and medical students...
www.FederalGrantsWire.com/nimh-administrative-supp...

Limited Competition: Addressing Health Disparities in Maternal and Child Health through Community-Based Participatory Research (R03)
This Funding Opportunity Announcement (FOA) encourages Small Research Project Grant (R03) applications to support community-based participatory research (CBPR) projects planned and developed by recipients of the Phase I Academic-Community...
www.FederalGrantsWire.com/limited-competition-addr...

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33)
This FOA provides funding to conduct pharmacodynamics, pharmacokinetics, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological...
www.FederalGrantsWire.com/innovation-grants-to-nur...

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33)
This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological...
www.FederalGrantsWire.com/innovation-grants-to-nur...

NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34)
NIDDK supports investigator-initiated, multi-center (three or more sites) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: (1) Permit early peer review of...
www.FederalGrantsWire.com/niddk-multi-center-clini...

NIDDK Multi-Center Clinical Study Cooperative Agreement (U01)
This FOA invites applications for investigator-initiated, multi-center clinical studies. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission...
www.FederalGrantsWire.com/niddk-multi-center-clini...

Building on High Impact Basic Neurobiology Through Assay Development: Advancing Tools for Therapeutic Discovery (R01)
This funding opportunity announcement (FOA) encourages research grant applications from institutions/organizations to develop novel, robust assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures...
www.FederalGrantsWire.com/building-on-high-impact-...

The NCI Transition Career Development Award (K22)
This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This...
www.FederalGrantsWire.com/the-nci-transition-caree...

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)
The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy. FDA...
www.FederalGrantsWire.com/clinical-studies-of-safe...